How has been the historical performance of Artemis Medicare?

Nov 12 2025 11:58 PM IST
share
Share Via
Artemis Medicare has shown significant growth, with net sales increasing from 408.40 crore in March 2021 to 936.92 crore in March 2025, and a net profit of 82.63 crore for the year ending March 2025, despite fluctuations in operating profit. The company's total assets rose to 1,357.41 crore, reflecting strong growth and expansion.
Answer:
The historical performance of Artemis Medicare shows significant growth in net sales and profitability over the years, culminating in a net profit of 82.63 crore for the year ending March 2025.

Breakdown:
Artemis Medicare's net sales have steadily increased from 408.40 crore in March 2021 to 936.92 crore in March 2025, reflecting a robust growth trajectory. The total operating income followed a similar trend, reaching 936.92 crore in March 2025, up from 554.80 crore in March 2022. Operating profit, however, saw fluctuations, with a notable increase to 140.05 crore in March 2024 before dropping to 0.00 in March 2025, while profit before tax also decreased to 0.00 in March 2025 from 68.45 crore in the previous year. Despite this, profit after tax rose significantly to 82.18 crore in March 2025, up from 49.14 crore in March 2024. The company's total assets increased to 1,357.41 crore in March 2025, compared to 971.51 crore in March 2024, indicating a strong asset base. Total liabilities also rose to 1,357.41 crore in March 2025, reflecting the company's growing financial commitments. Cash flow from operating activities improved to 145.00 crore in March 2025, while cash flow from investing activities showed a significant outflow of -385.00 crore, indicating substantial investments. Overall, Artemis Medicare's performance illustrates a period of growth and expansion, despite some volatility in operating profit and tax figures.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News